Do CRHR1 rs110402 AA and FKBP5 rs1360780 CT variants alter HPA-axis stress responses and cortisol regulation?

The hypothalamic-pituitary-adrenal (HPA) axis is the body’s primary system for managing physiological and psychological stress. Genetic variations in the genes regulating this system, specifically CRHR1 and FKBP5, significantly influence how individuals perceive and hormonally respond to stressors. For a 41-year-old female, these variants represent a biological predisposition for altered cortisol dynamics.

Clinical evidence of HPA-axis alterations

Research consistently identifies both the CRHR1 rs110402 AA and FKBP5 rs1360780 CT variants as key determinants of stress reactivity.

• CRHR1 rs110402 AA: Clinical studies using the Trier Social Stress Test (TSST) have demonstrated that individuals with the AA genotype exhibit significantly different cortisol trajectories compared to G-allele carriers. This often manifests as heightened cortisol reactivity, indicating a more sensitive stress-triggering mechanism in the brain.
• FKBP5 rs1360780 CT: This variant is strongly linked to impaired recovery from stress. Carrying the T-allele (as seen in the CT genotype) is associated with resistance to glucocorticoid-mediated negative feedback, leading to prolonged elevation of cortisol levels and higher cumulative exposure to stress hormones.

Mechanistic explanations

These genetic variants operate through distinct but complementary molecular pathways that govern the start and end of the stress response.

• Receptor signaling (CRHR1): The rs110402 variant is located within the gene for the corticotropin-releasing hormone receptor 1. The AA genotype alters the efficiency of these receptors in the pituitary and brain, effectively lowering the threshold required to initiate the HPA-axis cascade.
• Negative feedback inhibition (FKBP5): The FKBP5 protein acts as a "brake" on the glucocorticoid receptor (GR). The T-allele in the rs1360780 variant increases the production of FKBP5 protein. This excess protein prevents the GR from moving into the cell nucleus effectively, which delays the signal to stop producing cortisol. This results in a "sluggish" recovery where the body remains in a high-stress state for longer periods.

Bottom line

The CRHR1 rs110402 AA and FKBP5 rs1360780 CT variants are scientifically supported modulators of the HPA-axis. Together, they create a profile characterized by increased sensitivity to stress initiation and a delayed return to hormonal baseline, which may influence long-term metabolic and psychological health.